Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia

Venus Remedies on Monday said it has received approval to market a drug, which prevents blood clots, in Saudi Arabia. The company has received the marketing approval for Enoxaparin in pre-filled syringes, the drug firm said in a statement on Monday.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news